journal article·2020-02

An IR820 Dye–Protein Complex for Second Near‐Infrared Window and Photoacoustic Imaging

Bulin Du, Chunrong Qu, Kun Qian, Ying Ren, Yesen Li, Xiaohong Cui, Shuqing He, Yifan Wu, Timothy Ko, Ruiqi Liu, Xuena Li, Yaming Li, Zhen Cheng

Advanced Optical Materials· Volume 8· Issue 4
Publisher page

Abstract

Abstract Recently, much attention has been focused on the development of second near‐infrared window (NIR‐II, 1000–1700 nm) fluorescence imaging because of its reduced scattering, minimal absorption, and negligible autofluorescence. NIR‐II bioimaging allows the visualization of deep anatomical features with an unprecedented degree of clarity. In addition to the construction of a variety of new NIR‐II fluorophores, using a fluorescence tail emission greater than 1000 nm for conventional NIR‐I dyes represents a promising strategy for developing an NIR‐II imaging technique. Herein, the authors report tailoring a supramolecular assembly of human serum albumin (HSA) protein complexed with a sulfonated NIR‐I organic dye (IR820) to produce a brilliant 21‐fold increase in fluorescence for NIR‐II imaging. In vivo NIR‐II imaging with IR820–HSA allows noninvasive and dynamic visualization and monitoring of physiological and pathological conditions of the vascular system, lymphatic drainage system, and tumor‐bearing mice, as well as image‐guided tumor resection with high spatial and temporal resolution. Furthermore, photoacoustic imaging (PAI) of IR820–HSA in mouse tumor models also demonstrate good tumor accumulation. Overall, an IR820–protein complex with high biocompatibility can be easily constructed using a conventional NIR‐I dye that provides a new theranostic tool with high clinical translation potential.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nuclear Medicine The First Hospital of China Medical University Shenyang 110001 China

Molecular Imaging Program at Stanford (MIPS) Canary Center at Stanford for Cancer Early Detection Department of Radiology and Bio‐X Program School of Medicine Stanford University Palo Alto CA 94305‐5484 USA

Academy for Advanced Interdisciplinary Studies and Department of Biomedical Engineering Southern University of Science and Technology (SUSTech) Shenzhen 518055 China

Institute of Molecular Medicine College of Life and Health Sciences Northeastern University Shenyang 110000 China

Funding

National Natural Science Foundation of China

References (46)

Show source-provided references
1. 10.1039/C8CS00234G10.1039/C8CS00234G ↗
2. 10.1038/s41467-018-05113-810.1038/s41467-018-05113-8 ↗
3. 10.1038/s41565-018-0221-010.1038/s41565-018-0221-0 ↗
4. 10.1002/advs.20190204210.1002/advs.201902042 ↗
5. 10.1002/adhm.20190026010.1002/adhm.201900260 ↗
6. 10.1021/acs.nanolett.9b0014010.1021/acs.nanolett.9b00140 ↗
7. 10.1002/anie.20180122610.1002/anie.201801226 ↗
8. 10.1038/ncomms1526910.1038/ncomms15269 ↗
9. 10.1002/adom.20190022910.1002/adom.201900229 ↗
10. 10.1038/s41467-019-09043-x10.1038/s41467-019-09043-x ↗
11. 10.1002/smll.20190338210.1002/smll.201903382 ↗
12. 10.1038/nmat447610.1038/nmat4476 ↗
13. 10.1002/adfm.20170099510.1002/adfm.201700995 ↗
14. 10.1039/C7SC00251C10.1039/C7SC00251C ↗
15. 10.1021/acs.jmedchem.8b0168210.1021/acs.jmedchem.8b01682 ↗
16. 10.1002/anie.20190418210.1002/anie.201904182 ↗
17. 10.1073/pnas.171891711510.1073/pnas.1718917115 ↗
18. 10.7150/thno.2799510.7150/thno.27995 ↗
19. 10.2310/7290.2011.0003110.2310/7290.2011.00031 ↗
20. 10.2310/7290.2009.0000510.2310/7290.2009.00005 ↗
21. 10.1021/bc700356f10.1021/bc700356f ↗
22. 10.1002/adma.20140091410.1002/adma.201400914 ↗
23. 10.2147/IJN.S6955010.2147/IJN.S69550 ↗
24. 10.1016/j.biomaterials.2016.08.01610.1016/j.biomaterials.2016.08.016 ↗
25. 10.1002/smll.20180299410.1002/smll.201802994 ↗
26. 10.1016/j.biomaterials.2019.11927910.1016/j.biomaterials.2019.119279 ↗
27. 10.1016/j.addr.2018.07.01110.1016/j.addr.2018.07.011 ↗
28. 10.1016/j.biomaterials.2014.07.06210.1016/j.biomaterials.2014.07.062 ↗
29. 10.1016/j.biomaterials.2014.06.01310.1016/j.biomaterials.2014.06.013 ↗
30. 10.1117/1.JBO.24.4.04090110.1117/1.JBO.24.4.040901 ↗
31. 10.1002/adom.20190004510.1002/adom.201900045 ↗
32. 10.1002/adma.20180254610.1002/adma.201802546 ↗
33. 10.1074/jbc.M10057520010.1074/jbc.M100575200 ↗
34. 10.1016/j.jmb.2005.07.07510.1016/j.jmb.2005.07.075 ↗
35. 10.1248/bpb.25.69510.1248/bpb.25.695 ↗
36. 10.1002/advs.20160048410.1002/advs.201600484 ↗
37. 10.1103/PhysRevLett.96.11300210.1103/PhysRevLett.96.113002 ↗
38. 10.1016/j.tca.2012.07.00110.1016/j.tca.2012.07.001 ↗
39. 10.1016/j.jim.2007.11.01210.1016/j.jim.2007.11.012 ↗
40. 10.1038/s41598-018-23693-910.1038/s41598-018-23693-9 ↗
41. 10.1172/jci.insight.9086110.1172/jci.insight.90861 ↗
42. 10.1111/1471-0528.1217310.1111/1471-0528.12173 ↗
43. 10.1016/j.oraloncology.2012.07.01710.1016/j.oraloncology.2012.07.017 ↗
44. 10.1038/s41467-018-03505-410.1038/s41467-018-03505-4 ↗
45. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
46. 10.1002/adma.20160003810.1002/adma.201600038 ↗